Key terms

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest LGND news

Mar 08 8:45am ET Ligand Pharma (LGND) Gets a Buy from Craig-Hallum Mar 06 4:55am ET Ligand management to meet with Craig-Hallum Mar 02 1:06am ET Ligand Pharmaceuticals Inc’s New Competition Risk – A Cause for Worry? Mar 01 11:04am ET Biotech Alert: Searches spiking for these stocks today Feb 29 10:57am ET Biotech Alert: Searches spiking for these stocks today Feb 29 10:57am ET Biotech Alert: Searches spiking for these stocks today Feb 29 6:30am ET Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), Springworks Therapeutics (SWTX) Feb 28 7:32am ET Analysts Offer Insights on Healthcare Companies: Fulcrum Therapeutics (FULC), Ligand Pharma (LGND) and Alphatec Holdings (ATEC) Feb 28 3:40am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Ligand Pharma (LGND), Agilent (A) and Eli Lilly & Co (LLY) Feb 27 1:07pm ET Ligand management to meet with Craig-Hallum Feb 27 7:13am ET Ligand sees FY24 EPS $4.25 -$4.75, consensus $4.27 Feb 27 7:11am ET Ligand reports Q4 EPS $1.38, consensus 66c Feb 26 3:45am ET Ligand Pharma (LGND) Receives a Buy from Barclays Feb 23 9:03am ET Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Celcuity (CELC) Feb 22 4:13pm ET Ligand partner Eisai receives Japan approval for Fycompa injection Jan 29 5:06am ET Barclays Remains a Buy on Ligand Pharma (LGND) Jan 08 6:30am ET Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Neurogene (NGNE) and Gossamer Bio (GOSS) Jan 05 4:31pm ET Ligand announces FDA approval of ZELSUVMI Dec 18 9:31am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: NeuroOne Medical Technologies (NMTC), Invivyd (IVVD) and Ligand Pharma (LGND) Dec 13 10:35am ET Ligand Pharma: A Buy Rating on Strong Growth Prospects and Transition to Royalty Aggregation Model Dec 13 7:20am ET Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Ligand Pharma (LGND) and Syndax Pharmaceuticals (SNDX) Dec 12 12:04pm ET Ligand sees FY28 adjusted EPS $10.00-$10.50 Dec 12 12:02pm ET Ligand sees FY24 adjusted EPS $4.25-$4.75, consensus $4.17 Dec 12 9:15am ET Sermonix Pharmaceuticals shares PK, baseline data tied to Lasofoxifene trials

No recent news articles are available for LGND

No recent press releases are available for LGND

LGND Financials

1-year income & revenue

Key terms

LGND Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

LGND Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms